Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator agent with a beta-adrenergic agonist effect. It is thought to increase blood flow through peripheral vasodilation.
## Primary Indications
Treatment of peripheral vascular disease, such as intermittent claudication, and vasospastic disorders. Its efficacy in these conditions is not well-established.
## Adult Dosing
* **Initial:** 10 mg to 20 mg orally three to four times daily.
* **Maintenance:** Doses may be increased as needed.
* **Maximum:** No specific maximum dose is established in common literature, but doses exceeding 20 mg four times daily are generally not recommended. Dosing regimens may vary based on patient response and tolerability.
## Pediatric Dosing
No established pediatric dosing recommendations exist for isoxsuprine hydrochloride.
## Dose Adjustments
No specific dose adjustments for renal or hepatic impairment are established in common literature. Caution and close monitoring are advised in patients with significant renal or hepatic dysfunction.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use in patients with congenital heart disease or individuals where a significant increase in heart rate is undesirable.
## Adverse Effects
Common adverse effects include flushing, gastric upset, nausea, vomiting, dizziness, weakness, and hypotension. Tachycardia and palpitations may also occur.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Sympathomimetics:** Concomitant use may lead to additive cardiovascular effects (e.g., increased heart rate and blood pressure).
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease improvement.
* Adverse effects such as dizziness, nausea, and flushing.
## Clinical Pearls
* The clinical benefit of isoxsuprine hydrochloride in peripheral vascular disease is debated, and its use should be considered in the context of limited evidence.
* Administer with meals to minimize gastrointestinal upset.
* Discontinue if adverse effects are severe or persistent.
***
**Disclaimer:** This information is intended for clinical professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant literature for complete details.
